Search This Blog

Thursday, April 30, 2020

NovoCure EPS beats by $0.02, misses on revenue

NovoCure (NASDAQ:NVCR): Q1 GAAP EPS of $0.04 beats by $0.02.
Revenue of $101.83M (+38.9% Y/Y) misses by $0.27M.
Press Release
https://seekingalpha.com/news/3566663-novocure-eps-beats-0_02-misses-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)